BrightInsight Selects Lyniate to Enhance Interoperability

BOSTON & SAN JOSE, Calif.--(BUSINESS WIRE)--BrightInsight, provider of the leading global platform for biopharma and medtech regulated digital health solutions, today announced a strategic partnership with Lyniate, a global leader in healthcare data interoperability. BrightInsight selected Lyniate Envoy®, a managed service solution, to upgrade interoperability capabilities on its platform for regulated digital health solutions around the world. Lyniate’s experience with FHIR, HL7, X12, CCD, C-CDA, MFT, and other health data standards across various EHR vendors including Epic, Cerner, Meditech, and others, allows for digital health solutions to be utilized by healthcare providers within their existing workflow. Lyniate’s seamless data exchange capabilities will increase the value and impact of the regulated digital health solutions that are hosted on the BrightInsight Platform. BrightInsight will serve as underlying infrastructure for biopharma and medtech regulated digital health solutions, which require a reputable, flexible, data integration solution. Through this partnership, BrightInsight is able to connect Software as a Medical Device (SaMD) solutions to healthcare organizations in markets critical to biopharma and medtech companies, including the United States, Europe, and Asia Pacific,” said Erkan Akyuz, CEO of Lyniate. BrightInsight provides the leading global platform for biopharma and medtech regulated digital health solutions.